Enhanced safety in breast implants
|
|
- Mariah Alannah Mitchell
- 6 years ago
- Views:
Transcription
1 Enhanced safety in breast implants
2 Introduction Despite significant improvements in implant quality, rupture of breast implants is still possible If leak is suspected: Detection by palpation Experienced plastic surgeon is less than 30% accurate (Iwuagwu et al.; Br. J. Plast. Surg.1997) 70% leakage missed Ultrasound 70% specific 30% leakage missed MRI 91 % specific: Current golden standard Still 9% leakage missed
3 Introduction FDA recommends MRI 3 years post implantation and biannually thereafter Substantial evidence current imaging is imperfect Thus: Candidates for breast augmentation are reluctant due to risks of leakage of implants Enhanced detection of possible rupture gives women confidence in implant quality
4 Why do breast implants leak? Envelope integrity declines, possibly due to infiltration of lipids Implant failure: aging, per-implantation damage, thoracic trauma, closed capsulotomy A minimum of 15% of modern implants must be expected to rupture between 3 rd and 10 th year after implantation (Holmich et al.; Archives of Surgery 138, (2003))
5 Introduction After years of implantation rupture rate increases rapidly. Robinson et al.: 71 % of 300 explantees have time-dependent disruption of one or both implants Also, after implantation impact to implants can occur. Women often seek confirmation that the implant is still intact Detection method should be 100% conclusive Readily available in every hospital Fast Cost effective
6 The invention The basis of our invention is the use of relatively large contrast particles, which are dispersed homogenously in the cohesive gel of the breast prosthesis Particles are evenly distributed in crosslinked silicone gel and can not move through gel (confirmed by >10G spinning) Easy to implement in production process
7 The invention The particles can be made visible on: MRI and/or X-ray and/or CT and/or Ultrasound Particles can be seen individually Particles can have different shapes (mass: g; volume: μl) Can easily be differentiated from other radiological conditions (eg. breast cancer)
8 The invention Particles are composed of Pebax with well-established biocompatibility (eg. pacemaker leads) Contrast agent is dispersed in each particle. The actual contrast agent can be: MRI: ferromagnetic iron, paramagnetic iron X-ray: BaSO 4 Ultrasound: Hollow gas-filled particles The use of Pebax to contain the contrast agents is our key novum, and it is an important safety issue The presence of the particles in the gel does not influence the gel s softness or other rheological parameters
9 Intact and leaking implant with Pebax particles
10 The invention Implant failure: Cohesive gel and particles leak ouside envelope, Pebax/contrast particles will be located outside the envelope 100% MRI and/or X-ray and/or CT and/or ultrasound visible No false positive of false negative results No more missing of 9% false negative leaking implants (MRI: current gold standard)
11 Experiment Two breast prostheses were filled with a cohesive gel + Pebax particles dispersed therein. The particles contained 5% (by mass) bariumsulfate, which rendered them visible on CT images, NOT on MRI The prostheses were implanted in a porcine cadaver following a routine surgical protocol One of the prostheses was artificially damaged at and some of the gel (+ particles) was forced out of the envelope MRI and CT images were made It could be established clearly that one implant was intact, while the other was leaking
12 Implantation in porcine cadaver model Breast implant with the contrast particles (blue) dispersed in the gel. Here, the intact implant is inserted into the porcine cadaver model
13 CT vs. MRI CT MRI Doubtful leaking on MRI (right, red arrow) clearly visible on CT (left, blue arrow)
14 CT MRI Representative plot from CT imaging, showing the two breast implants. Contrast particles inside both envelopes (left) are clearly visible. Some contrast particles are seen outside the envelope of the left implant (blue arrow), revealing the leak made in this breast implant Leaking of content is more elaborate than visible on MRI (right, red arrow)
15 Implications for marketing Patients demand safest implant from their surgeon Surgeons and implant manufacturer want safest implants for their clients Patient satisfaction Medicolegal aspects Improved safety of implant increases quality difference to other brands
16 Implications for marketing Unique selling point Owner of patent will increase market share Owner of patent will increase patient satisfaction product quality production numbers of implants company profits
17 Conclusions Leaking of implant now 100% detectable Cost effective and fast detection Enhanced patient confidence in product Easy to implement in production process 100% safety of implant is unique selling point
18 (WO/2010/047587) I MPLANT FOR PROSTHESES Patent Latest bibliographic data on file with the International Bureau Pub. No.: WO/2010/ International Application No.: PCT/NL2009/ Publication Date: International Filing Date: IPC: A61L 27/50 ( ), A61L 31/10 ( ) Applicants: Inventors: Agent: HACTA B.V. [NL/NL]; Bolderik 9 NL-6271 EC Gulpen (NL) (All Except US). KOOLE, Levinus Hendrik [NL/NL]; (NL) (US Only). DUMONT, Ewald Anna Wilhelmus Jozef [NL/NL]; (NL) (US Only). DUMEDIC B.V. [NL/NL]; Levignelunet 11 C 6221 KM Maastricht (NL) (All Except US). KOOLE, Levinus Hendrik; (NL). DUMONT, Ewald Anna Wilhelmus Jozef; (NL). HATZMANN, M.J.; Vereenigde Johan de Wittlaan 7 NL-2517 JR Den Haag (NL). Priority Data: EP Title: Abstract: Designated States: IMPLANT FOR PROSTHESES The invention is directed to an implant comprising an envelope filled with a core filling material, such as breast implants and implants for aesthetic and reconstructive surgery, comprising at least one biocompatible gel material and evenly dispersed through the gel material at least one particulate radiopaque, MRI and/or ultra- sound visible material, wherein the core filling material is viscoelastic at 37 C, having a viscosity in the range of 10 to 108 cp. AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. African Regional Intellectual Property Org. (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW) Eurasian Patent Organization (EAPO) (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM) European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR) African Intellectual Property Organization (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
(43) Publication date: 04 September 2014 ( ) (22) Filing Date: 27 February 2014 ( )
(54) Title (EN): INCOHERENT TYPE-III MATERIALS FOR CHARGE CARRIERS CONTROL DEVICES (54) Title (FR): MATÉRIAUX DE TYPE III INCOHÉRENTS POUR DISPOSITIFS DE RÉGULATION DE PORTEURS DE CHARGES (72) Inventor(s):
More informationWO 2012/ A3. 15 November 2012 ( ) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More information(43) International Publication Date. 15 July 2010 ( ) WO 2010/ A3. (19) World Intellectual Property Organization International Bureau
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date (10) International
More informationWO 2014/ A3 P O P C T. 6 February 2014 ( )
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More informationCalypso Application. License for card and portable objects.
Calypso Application License for card and portable objects. I N N O V A T R O N CalypsoLicense page 1 / 6 Innovatron, 27 rue de Bassano, 75008 Paris, France 1. License Policy General Presentation Innovatron
More information(10) International Publication Number (43) International Publication Date WO 2013/ A3 20 June 2013 ( ) W P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More informationWO 2013/ A3. 10 October 2013 ( ) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More informationDNA Phosphodiesterase 1. Tyrosyl DNA Phosphodiesterase 1 is a very im ADMET predicted profile-classification
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More information(81) Designated States (unless otherwise indicated, for every
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date (10) International
More informationI International Bureau (10) International Publication Number (43) International Publication Date
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International
More informationWO 2014/ A3. 23 October 2014 ( ) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More informationWO 2016/ Al FIG. 2A. 23 June 2016 ( ) P O P C T. v o
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More informationWO 2016/ Al. 20 October 2016 ( ) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More informationI International Bureau (10) International Publication Number (43) International Publication Date
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International
More informationWO 2012/ Al. (10) International Publication Number (43) International Publication Date. 9 August 2012 ( )
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More informationPCT. (71) Applicant: ABBVIE INC. [US/US]; I North Waukegan Road, North Chicago, Illinois (US), English. English US US US US US US US I US)
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 25 April 2013 (25.04.2013)
More informationWO 2018/ Al. (43) International Publication Date 07 June 2018 ( ) W!P O PCT
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More information(43) International Publication Date WO 2017/ Al 27 July 2017 ( ) W P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More informationTEPZZ _7584 A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: A61K 9/00 ( ) A61K 31/439 (2006.
(19) TEPZZ _784 A_T (11) EP 3 17 842 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: 07.06.17 Bulletin 17/23 (1) Int Cl.: A61K 9/00 (06.01) A61K 31/439 (06.01) (21) Application number: 1197874.9
More informationWO 2015/ Al. 21 May 2015 ( ) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More informationAttention. Therefore, all the data and statements made in this presentation are preliminary and might change in the future.
Attention The aim of the Dose Datamed II workshop in Athens was to present preliminary data, collect feedback from the audience and to work towards final results and conclusions. Therefore, all the data
More informationI International Bureau (10) International Publication Number (43) International Publication Date
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International
More informationTEPZZ 85_Z 4A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION
(19) TEPZZ 8_Z 4A_T (11) EP 2 81 034 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: 2.03.1 Bulletin 1/13 (21) Application number: 1022.2 (1) Int Cl.: A61C /02 (06.01) A61C 19/04 (06.01)
More informationo (54) Title: COLD PREPARED GEL AND METHOD FOR MAKING SAME WO 2012/ Al 4 October 2012 ( ) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More informationWO 2016/ Al. S between 20N and 200N and friability value is less than 0.6%. 20 October 2016 ( ) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More information(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT)
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More information(43) International Publication Date WO 2014/ Al 26 June 2014 ( ) W P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More information(43) International Publication Date WO 2015/ Al 7 May 2015 ( ) W P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More informationPCT. ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, Herlev (DK).
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date (10) International
More informationC IED in the EU from a military perspective. UN CCW AP II C IED Experts Meeting 8 & 9 April 2013
C IED in the EU from a military perspective UN CCW AP II C IED Experts Meeting 8 & 9 April 2013 Agenda EEAS & EUMS EDA Background projects European External Action Service Based on a Common Foreign and
More informationImplementation Report on the patient safety Recommendation 2009/C 151/01. Healthcare Systems Unit DG SANCO
Implementation Report on the patient safety Recommendation 2009/C 151/01 Healthcare Systems Unit DG SANCO Published 15 November 2012 REPORT FROM THE COMMISSION TO THE COUNCIL on the basis of Member States'
More informationLIMITE EN COUNCIL OF THE EUROPEAN UNION. Brussels, 7 July /11 LIMITE ENFOPOL 228 DAPIX 81
COUNCIL OF THE EUROPEAN UNION Brussels, 7 July 2011 12390/11 LIMITE ENFOPOL 228 DAPIX 81 NOTE From: Presidency To: Law Enforcement Working Party No. prev. doc.: CM 1508/11 Subject: Results of the questionnaire
More informationList of nationally authorised medicinal products
10 September 2015 EMA/677092/2015 Procedure Management and Committees Support Active substance: glatiramer Procedure no.: PSUSA/00001529/201411 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
More informationPharmaceutical Pricing & Reimbursement Information. PPRI Project Co-ordination Sabine Vogler, Gesundheit Österreich GmbH
PPRI - Comparative Analysis PPRI Project Co-ordination Sabine Vogler, Gesundheit Österreich GmbH PPRI Conference Vienna, 29 June 2007 PPRI Conference, Vienna, 29 June 2007 1 Comparative Analysis - Outline
More informationWO 2015/ Al. 5 November 2015 ( ) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More informationMedia monitoring: Experience of outbreak monitoring at ECDC to monitor vaccine safety potential crisis- A pilot using MediSYS
Media monitoring: Experience of outbreak monitoring at ECDC to monitor vaccine safety potential crisis- A pilot using MediSYS Building Trust, Managing Risk: Vaccine Confidence and Human Papillomavirus
More informationAt-A-Glance report 2013
At-A-Glance report 213 Cystic Fibrosis in Europe Facts and Figures 213 The European Cystic Fibrosis Society Patient Registry (ECFSPR) is happy to present this report with key information about how cystic
More informationINNOVATION THAT REALLY MATTERS. Prof. Lina Badimon. Institut Català de Ciències Cardiovasculars (ICCC), Barcelona
INNOVATION THAT REALLY MATTERS Prof. Lina Badimon, Barcelona THE INSTITUTION THE INSTITUTION THE ICCC CATALAN INSTITUTE FOR CARDIOVASCULAR SCIENCE (ICCC) Objectives LEADING AN STRATEGIC PLANNING IN CVR
More informationOverview of Study Experience (CEOs, only)
CLINVICES GmbH_x000D_ Experience CEOs_x000D_ Status: February 2015_x000D_ Hypertension III 78 350 DE MAY 1997 - DEC 1998 Leg Ventricular Hypertrophy Leg Ventricular Hypertrophy Atopic Dermahhs in children
More informationPublished: with international search report (Art. 21(3))
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More informationEP A1 (19) (11) EP A1. (12) EUROPEAN PATENT APPLICATION published in accordance with Art. 153(4) EPC
(19) (12) EUROPEAN PATENT APPLICATION published in accordance with Art. 13(4) EPC (11) EP 2 07 001 A1 (43) Date of publication: 01.07.2009 Bulletin 2009/27 (21) Application number: 07834499.1 (22) Date
More informationEP A2 (19) (11) EP A2 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2009/16
(19) (12) EUROPEAN PATENT APPLICATION (11) EP 2 047 749 A2 (43) Date of publication: 1.04.09 Bulletin 09/16 (21) Application number: 0838028.0 (22) Date of filing: 07..08 (84) Designated Contracting States:
More informationP CT. desi, No: 14, Istinye/Sariyer, Istanbul (TR). Published:
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More informationI International Bureau (10) International Publication Number (43) International Publication Date 6 December 2012 ( )
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International
More informationTrends in injecting drug use in Europe
Trends in injecting drug use in Europe Linda Montanari, Bruno Guarita and Danica Thanki Annual Expert Meeting on Drug-Related Infectious Diseases Lisbon, 15-17 October Overview of the presentation 1) Information
More informationP O P C T. Published: Figure 1
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More informationAt-A-Glance report 2014
At-A-Glance report 14 Cystic Fibrosis in Europe Facts and Figures 14 The European Cystic Fibrosis Society Patient Registry (ECFSPR) is happy to present this report with key information about how cystic
More informationEP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2012/28
(19) (12) EUROPEAN PATENT APPLICATION (11) EP 2 474 288 A1 (43) Date of publication: 11.07.2012 Bulletin 2012/28 (51) Int Cl.: A61F 2/40 (2006.01) A61F 2/30 (2006.01) (21) Application number: 11150615.0
More informationEUROPEAN MEDICINES AGENCY DECISION. of 20 July 2008
European Medicines Agency Doc. Ref. EMEA/357907/2008 P/53/2008 EUROPEAN MEDICINES AGENCY DECISION of 20 July 2008 on the application for agreement of a Paediatric Investigation Plan for Atorvastatin calcium
More informationPorta Potti Qube Campa Potti Qube User Manual
Porta Potti Qube Campa Potti Qube User Manual QUICK GUIDE Preparing waste-holding tank 1 2 3 QUICK GUIDE Emptying waste-holding tank 10 11 12 4 5 6 13 14 15 Preparing flush-water tank Emptying flush-water
More informationPublic administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective
Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective Prof. Ing. Juraj Nemec, CSc. Masaryk University, Czech Republic, Size of government
More informationDeclaration of conformity Adapter
Declaration of conformity acc. to VO (EG) 1935/2004 and VO (EU) 10/2011 as well as acc. to FDA Document ID: 34466 Editing status: 2017-05-19 2 CFR FDA stands for Food and Drug Administration, a U.S. authority.
More informationSpreading Excellence and Widening Participation
Spreading Excellence and Widening Participation Dr G Ambroziewicz Ankara, 27/02/2017 Research and Background Disparities in research and innovation performance: barrier to competitiveness, growth and jobs
More informationNew trends in harm reduction in Europe: progress made challenges ahead
New trends in harm reduction in Europe: progress made challenges ahead Dagmar Hedrich, Alessandro Pirona, EMCDDA 2 nd European Harm Reduction Conference, 7-9 May 2014, Basel Session 4: Changes in harm
More informationTEPZZ _ 849 A_T EP A1 (19) (11) EP A1. (12) EUROPEAN PATENT APPLICATION published in accordance with Art.
(19) TEPZZ _ 849 A_T (11) EP 3 138 493 A1 (12) EUROPEAN PATENT APPLICATION published in accordance with Art. 3(4) EPC (43) Date of publication: 08.03.17 Bulletin 17/ (21) Application number: 786271. (22)
More informationMeasuring DNSSEC Use. Geoff Huston APNIC Labs
Measuring DNSSEC Use Geoff Huston APNIC Labs We all know What DNSSEC does And why it s a Good Thing to sign your DNS zones using DNSSEC But s that s a supply side acavity. What about the demand side? If
More information(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( )
(19) TEPZZ 94677_A_T (11) (12) EUROPEAN PATENT APPLICATION (43) Date of publication: 2.11.1 Bulletin 1/48 (1) Int Cl.: A61K 9/ (06.01) A61K 31/41 (06.01) (21) Application number: 116790.3 (22) Date of
More informationNon-reproductive tissues and cells
Colour key Minimum requirements as set out in Directive 2004/23/EC and its technical Directives (particularly 2006/17/EC) More stringent -legally binding, applies for all donations and all donor profiles
More information22 April 2010 ( ) WO 2010/ Al
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date (10) International
More informationWorking Group on Population Statistics
EUROPEAN COMMISSION EUROSTAT Directorate F: Social statistics Unit F-2: Population and migration Luxembourg, 13 October 2017 ESTAT/F2/POP/2017/WG1/03/SAR/GSB Working Group on Population Statistics Luxembourg,
More informationEIIW Competitiveness Report on the EU Market
EIIW Competitiveness Report on the EU Market Jens K. Perret Wuppertal, January 215 Preliminary European Institute for International Economic Relations at the University of Wuppertal, Rainer-Gruenter-Str.
More information(12) STANDARD PATENT (11) Application No. AU B2 (19) AUSTRALIAN PATENT OFFICE
(12) STANDARD PATENT (11) Application No. AU 2011283648 B2 (19) AUSTRALIAN PATENT OFFICE (54) Title METHOD FOR REPAIRING PIPING (51) International Patent Classification(s) F16L 41/02 (2006.01) F16L 55/18
More informationPalliative nursing care of children and young people across Europe
Palliative nursing care of children and young people across Europe Results of a postal survey in August 2016 Updated in April 2017 (presented at the 29th PNAE-meeting in Naples/Italy on 28th April 2017)
More informationAppendix A: International Classification of Diseases, 10th Revision, Clinical Modification Codes (ICD-10) Utilized for VTE Events
Online Appendices to Mahan et al. External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR) (Thromb Haemost 2014; 112.4) Appendix
More information(51) Int Cl.: A61K 9/00 ( ) A61K 31/198 ( ) A61K 47/26 ( )
(19) TEPZZ 8Z6B_T (11) EP 2 8 06 B1 (12) EUROPEAN PATENT SPECIFICATION (4) Date of publication and mention of the grant of the patent: 08.06.16 Bulletin 16/23 (21) Application number: 1171684.2 (22) Date
More information(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) PCT
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date (10) International
More informationItem 2.2 Household definition
EUROPEAN COMMISSION EUROSTAT Directorate F: Social statistics Doc. DSSB/2016/Jun/2.2 Item 2.2 Household definition MEETING OF THE BOARD OF THE EUROPEAN DIRECTORS OF SOCIAL STATISTICS LUXEMBOURG, 28 AND
More informationConsequence of the change in the definition of. an agricultural parcel
Ispra, 03-04 April 2008 Kick-off Meeting of the 2008 CwRS Campaign 1 Consequence of the change in the definition of Andrew ROWLANDS MARS-PAC, JRC Ispra an agricultural parcel Ispra, 03-04 April 2008 Kick-off
More informationEnsuring protection of public health and patients in member states: priorities, constraints, opportunities
Ensuring protection of public health and patients in member states: priorities, constraints, opportunities Dr. Christa Wirthumer-Hoche AGES Austrian Medicines and Medical Devices Agency Vienna, Austria
More informationResults of the Survey addressed to the EU Member States about quantification of food waste and preventing Food waste Brussels,
Results of the Survey addressed to the EU Member States about quantification of food waste and preventing Food waste Brussels, 29.11.2016 Survey Number of addressed countries: 29 28 (EU Member States)
More informationScreening programmes for Hepatitis B/C in Europe
Programme STI, HIV/AIDS and viral hepatitis Screening programmes for Hepatitis B/C in Europe Mika Salminen, Ph.D. European Centre for Disease Prevention and Control Why might screening be needed for hepatitis
More informationT h e g l o b a l d i s t r i b u t i o n of r o u t i n e a n d n o n - r o u t i n e w o r k. F i n d i n g s f r o m P I A A C, S T E P & C U L S
T h e g l o b a l d i s t r i b u t i o n of r o u t i n e a n d n o n - r o u t i n e w o r k. F i n d i n g s f r o m P I A A C, S T E P & C U L S P i o t r L e w a n d o w s k i ( I B S, I Z A ) W o
More informationPCT WO 2009/ Al
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date (10) International
More informationReport from the CMD(h) meeting held on 17 th and 18 th March 2008
Report from the CMD(h) meeting held on 17 th and 18 th March 2008 CMD(h)/EMEA Sub-Group on Paediatric Regulation Further to the line listings received for authorised medicinal products (including purely
More informationEP A2 (19) (11) EP A2 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2011/42
(19) (12) EUROPEAN PATENT APPLICATION (11) EP 2 377 14 A2 (43) Date of publication: 19..11 Bulletin 11/42 (21) Application number: 10329.0 (1) Int Cl.: A61K 9/00 (06.01) A61K 31/13 (06.01) A61K 31/167
More informationPCT. (10) International Publication Number WO 2014/ A1
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 5 June 2014 (05.06.2014)
More information12 November 2009 ( ) WO 2009/ Al
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date (10) International
More information25 February 2010 ( ) WO 2010/ Al
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date (10) International
More informationo o WO 2015/ Al (10) International Publication Number (43) International Publication Date 23 July 2015 (23.07.
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
More informationT h e g l o b a l d i s t r i b u t i o n of r o u t i n e a n d n o n - r o u t i n e w o r k. F i n d i n g s f r o m P I A A C, S T E P & C U L S
T h e g l o b a l d i s t r i b u t i o n of r o u t i n e a n d n o n - r o u t i n e w o r k. F i n d i n g s f r o m P I A A C, S T E P & C U L S P i o t r L e w a n d o w s k i ( I B S, I Z A ) W o
More informationPCT. Figu re 2. (43) International Publication Date. 15 September 2011 ( ) WO 2011/ A9
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date CORRECTED VERSION
More informationEURL-SRM - Analytical Observations Report
concerning the following EURL-SRM - Analytical Observations Report o Compound(s): AMTT (metabolite of tritosulfuron) o Commodities: Fruit and vegetables, cereals o Extraction Method(s): o Instrumental
More informationTransmission, processing and publication of HBS 2015 data
EUROPEAN COMMISSION EUROSTAT Directorate F: Social statistics Unit F-4: Income and living conditions; Quality of life Doc. LC-ILC/194/17/EN estat.f.4 (2017) WORKING GROUP ON INCOME AND LIVING CONDITIONS
More informationUpdate on EEA s near real time air quality data exchange
Update on EEA s near real time air quality data exchange Jaume Targa (EEA ETC/ACC) Acknowledgement Thanks to all nrt data providers Currently there are 71 providers Latvian Environment, Geology and Name
More informationFinnish international trade 2017 Figures and diagrams. Finnish Customs Statistics
Finnish international trade 217 Figures and diagrams Finnish Customs Statistics IMPORTS, EXPORTS AND TRADE BALANCE 199-217 Billion e 7 6 5 4 3 2 1-1 9 91 92 93 94 95 96 97 98 99 1 2 3 4 5 6 7 8 9 1 11
More informationPatient reporting update
Patient reporting update François Houÿez Director of Treatment Information & Access, EURORDIS 8 th Pharmacovigilance stakeholders forum EMA, 15/06/2014 15/09/2014 eurordis.org 1 Spontaneous reporting in
More informationVARIATIONS : IMPACT ON ADMINISTRATIVE BURDEN AND FEES. Rose-Marie Molina EMA Infoday London, 14th March 2014
Rose-Marie Molina EMA Infoday London, 14th March 2014 Before 1234/2008 Regulation, variation procedures in the European Union for industry was synonymous of: - Lack of visibility about timelines - Lack
More informationRC4-1. User s instructions RC4-1 remote control
RC4-1 User s instructions RC4-1 remote control The remote control and any other parts shown in these user s instructions may not look the same as the one(s) you have. We furthermore reserve the right to
More informationImplementation of Smoke-free laws in the EU: Measures by Member State (Situation as of June 2009)
MS Scope of current regulation Entry into force Further developments 1. Total protection in all enclosed workplaces and public places (smoking banned altogether) IE Ban on smoking in all enclosed workplaces
More informationFinnish international trade 2017 Figures and diagrams. Finnish Customs Statistics
Finnish international trade 217 Figures and diagrams Finnish Customs Statistics IMPORTS, EXPORTS AND TRADE BALANCE 199-217 Billion e 7 6 5 4 3 2 1-1 9 91 92 93 94 95 96 97 98 99 1 2 3 4 5 6 7 8 9 1 11
More informationEU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017
EU Market Situation for Poultry Committee for the Common Organisation of the Agricultural Markets 2 April 217 -9.% -11.% -5.% -.1% -.7% -2.2% 3.% 1.7% 1.2%.8%.6%.%.%.% 7.9% 7.% 6.4% 6.2% 6.% 5.5% 5.3%
More informationSpherical Bearings Heavy Duty Equipments
Spherical Bearings Heavy Duty Equipments Highlights Quality Service Price Wbf Replacement Parts adaptableto > Caterpillar >Komatsu >Volvo 1 WBF SPHERICAL BEARINGS adaptable to Caterpillar Part No. Description
More informationVariations & worksharing An industry perspective
Variations & worksharing An industry perspective Rémon van Aubel European Medicines Agency/IFAH-Europe Info Day 7-8 March 2013, London 1 Variations - Regulation Commission Regulation (EU) No 1234/2008
More informationThe European Commission s science and knowledge service Smart Baltic
The European Commission s science and knowledge service Joint Research Centre S3P ENERGY WORKSHOP Smart Baltic Smart grid challenges and opportunities in the Baltic region flaviagangale@ec.europa.eu JRC
More informationEU School Fruit, Vegetables & Milk Scheme 2017/2023
EU School Fruit, Vegetables & Milk Scheme 2017/2023 What's new High Level Group on Nutrition and Physical Activities Brussels, 29/11/2017 AGRI.G.3 What's new since last High Level Group meeting By 31/7/2017
More informationState of play of Leader/CLLD preliminary analysis
State of play of Leader/CLLD preliminary analysis #LeaderCLLD Urszula Budzich-Tabor, ENRD CP Brussels, 23 June 2015 DG AGRI analysis of draft RDPs Indicative allocation of budget for LEADER (total public):
More informationAdvances and Innovations in Breast Reconstruction and Brest Surgery Presented by PCMC plastic surgeons
Advances and Innovations in Breast Reconstruction and Brest Surgery Presented by PCMC plastic surgeons Options for reconstruction after mastectomy Implants Autologous tissue = from your own body: skin
More informationHow sarcoma/gist research & expert care are organized in Italy
How sarcoma/gist research & expert care are organized in Italy Organization of care Historical migration for medical care PR VA LC VI TV BG LU GR PG CN AL MI Desi o LO PV Alzano Lombardo CO Casalpusterlen
More information*EP A1* EP A1 (19) (11) EP A1. (12) EUROPEAN PATENT APPLICATION published in accordance with Art.
(19) Europäisches Patentamt European Patent Office Office européen des brevets *EP00147089A1* (11) EP 1 47 089 A1 (12) EUROPEAN PATENT APPLICATION published in accordance with Art. 18(3) EPC (43) Date
More informationEUROPEAN COMMISSION DIRECTORATE GENERAL FOR HEALTH AND FOOD SAFETY
Ref. Ares(2016)5909621-13/10/2016 EUROPEAN COMMISSION DIRECTORATE GENERAL FOR HEALTH AND FOOD SAFETY Directorate B - Health systems, medical products and innovation B4 Medical products: quality, safety
More information